China women's healthcare market is expected to grow at an annual compound rate of 20 percent between 2010 and 2015. Some segments, like anti-aging and reproductive health, will see growth as high as 35 percent, with the market expected to hit 247 billion RMB, according to data from the Ministry of Health.

The co-operation between GC-Rise and Georgetown University showcases the rising trend in partnerships between American universities and international companies said Daniel Zohorsky, a member of the MBA team working with GC-Rise.

A primary advantage of working with GC-Rise is that "since it is a start-up, it feels great to be part of something that is growing. Our team gets to see where the company is headed in the future", said David Roehrenbeck. Started in 2008, GC-Rise is a relatively new company, but has witnessed rapid growth over past few years.

"What sets GC-Rise apart from other Chinese pharmaceutical companies is that it fills a niche (the women's health market)," Roehrenbeck added.

As GC-Rise continues to grow and Georgetown's Global Residency Program expands across borders, the partnership will be strengthened further.